|
1
|
Smith DJ, Lapedes AS, de Jong JC,
Bestebroer TM, Rimmelzwaan GF, Osterhaus AD and Fouchier RA:
Mapping the antigenic and genetic evolution of influenza virus.
Science. 305:371–376. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheung CY, Poon LL, Lau AS, Luk W, Lau YL,
Shortridge KF, Gordon S, Guan Y and Peiris JS: Induction of
proinflammatory cytokines in human macrophages by influenza A
(H5N1) viruses: A mechanism for the unusual severity of human
disease? Lancet. 360:1831–1837. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim H, Webster RG and Webby RJ: Influenza
virus: Dealing with a drifting and shifting pathogen. Viral
Immunol. 31:174–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Medina RA and Garcia-Sastre A: Influenza A
viruses: New research developments. Nat Rev Microbiol. 9:590–603.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hiscott J: Convergence of the NF-kappaB
and IRF pathways in the regulation of the innate antiviral
response. Cytokine Growth Factor Rev. 18:483–490. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Julkunen I, Sareneva T, Pirhonen J, Ronni
T, Melén K and Matikainen S: Molecular pathogenesis of influenza A
virus infection and virus-induced regulation of cytokine gene
expression. Cytokine Growth Factor Rev. 12:171–180. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Veckman V, Osterlund P, Fagerlund R, Melén
K, Matikainen S and Julkunen I: TNF-alpha and IFN-alpha enhance
influenza-A-virus-induced chemokine gene expression in human A549
lung epithelial cells. Virology. 345:96–104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li R and Wang L: Baicalin inhibits
influenza virus A replication via activation of type I IFN
signaling by reducing miR-146a. Mol Med Rep. 20:5041–5049.
2019.PubMed/NCBI
|
|
9
|
Downey J, Pernet E, Coulombe F, Allard B,
Meunier I, Jaworska J, Qureshi S, Vinh DC, Martin JG, Joubert P and
Divangahi M: RIPK3 interacts with MAVS to regulate type I
IFN-mediated immunity to influenza A virus infection. PLoS Pathog.
13:e10063262017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Munir M, Zohari S and Berg M:
Non-structural protein 1 of avian influenza A viruses
differentially inhibit NF-κB promoter activation. Virol J.
8:3832011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruckle A, Haasbach E, Julkunen I, Planz O,
Ehrhardt C and Ludwig S: The NS1 protein of influenza A virus
blocks RIG-I-mediated activation of the noncanonical NF-κB pathway
and p52/RelB-dependent gene expression in lung epithelial cells. J
Virol. 86:10211–10217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao S, Song L, Li J, Zhang Z, Peng H,
Jiang W, Wang Q, Kang T, Chen S and Huang W: Influenza A
virus-encoded NS1 virulence factor protein inhibits innate immune
response by targeting IKK. Cell Microbiol. 14:1849–1866. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hayashi T, MacDonald LA and Takimoto T:
Influenza A virus protein PA-X contributes to viral growth and
suppression of the host antiviral and immune responses. J Virol.
89:6442–6452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kincaid RP and Sullivan CS: Virus-encoded
microRNAs: An overview and a look to the future. PLoS Pathog.
8:e10030182012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cullen BR: Viruses and microRNAs. Nat
Genet. 38 (Suppl 1):S25–S30. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sullivan CS, Grundhoff A, Tevethia S,
Treisman R, Pipas JM and Ganem D: Expression and function of
microRNAs in viruses great and small. Cold Spring Harb Symp Quant
Biol. 71:351–356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ho BC, Yu IS, Lu LF, Rudensky A, Chen HY,
Tsai CW, Chang YL, Wu CT, Chang LY, Shih SR, et al: Inhibition of
miR-146a prevents enterovirus-induced death by restoring the
production of type I interferon. Nat Commun. 5:33442014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Y, Chen J, Wang H, Shi J, Wu K, Liu
S, Liu Y and Wu J: HCV-induced miR-21 contributes to evasion of
host immune system by targeting MyD88 and IRAK1. PLoS Pathog.
9:e10032482013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang F, Lin X, Yang X, Lu G, Zhang Q and
Zhang C: MicroRNA-132-3p suppresses type I IFN response through
targeting IRF1 to facilitate H1N1 influenza A virus infection.
Biosci Rep. 39:BSR201927692019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu X, He Z, Hu Y, Wen W, Lin C, Yu J, Pan
J, Li R, Deng H, Liao S, et al: MicroRNA-30e* suppresses dengue
virus replication by promoting NF-κB-dependent IFN production. PLoS
Negl Trop Dis. 8:e30882014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan B, Ma H, Jiang S, Shi J, Yang Z, Zhu
W, Kong C, Chen L, Yan H and Ma C: microRNA-221 restricts human
cytomegalovirus replication via promoting type I IFN production by
targeting SOCS1/NF-κB pathway. Cell Cycle. 18:3072–3084. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu H and Gu X: MicroRNA-221 inhibits human
papillomavirus 16 E1-E2 mediated DNA replication through activating
SOCS1/Type I IFN signaling pathway. Int J Clin Exp Pathol.
12:1518–1528. 2019.PubMed/NCBI
|
|
24
|
Du H, Cui S, Li Y, Yang G, Wang P, Fikrig
E and You F: MiR-221 negatively regulates innate anti-viral
response. PLoS One. 13:e02003852018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ding Y, Wang L, Zhao Q, Wu Z and Kong L:
MicroRNA-93 inhibits chondrocyte apoptosis and inflammation in
osteoarthritis by targeting the TLR4/NF-κB signaling pathway. Int J
Mol Med. 43:779–790. 2019.PubMed/NCBI
|
|
27
|
Nakamura S, Horie M, Daidoji T, Honda T,
Yasugi M, Kuno A, Komori T, Okuzaki D, Narimatsu H, Nakaya T and
Tomonaga K: Influenza A virus-induced expression of a GalNAc
transferase, GALNT3, via MicroRNAs is required for enhanced viral
replication. J Virol. 90:1788–1801. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Terán-Cabanillas E, Montalvo-Corral M,
Silva-Campa E, Caire-Juvera G, Moya-Camarena SY and Hernández J:
Production of interferon α and β, pro-inflammatory cytokines and
the expression of suppressor of cytokine signaling (SOCS) in obese
subjects infected with influenza A/H1N1. Clin Nutr. 33:922–926.
2014. View Article : Google Scholar
|
|
29
|
Subbarao K and Joseph T: Scientific
barriers to developing vaccines against avian influenza viruses.
Nat Rev Immunol. 7:267–278. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chiang C, Chen GW and Shih SR: Mutations
at alternative 5′ splice sites of M1 mRNA negatively affect
influenza A virus viability and growth rate. J Virol.
82:10873–10886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pichlmair A, Schulz O, Tan CP, Näslund TI,
Liljeström P, Weber F and Reis e Sousa C: RIG-I-mediated antiviral
responses to single-stranded RNA bearing 5′-phosphates. Science.
314:997–1001. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prêle CM, Woodward EA, Bisley J,
Keith-Magee A, Nicholson SE and Hart PH: SOCS1 regulates the IFN
but not NFkappaB pathway in TLR-stimulated human monocytes and
macrophages. J Immunol. 181:8018–8026. 2008. View Article : Google Scholar
|
|
33
|
Nakahara T, Tanaka K, Ohno S, Egawa N,
Yugawa T and Kiyono T: Activation of NF-κB by human papillomavirus
16 E1 limits E1-dependent viral replication through degradation of
E1. J Virol. 89:5040–5059. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gack MU, Albrecht RA, Urano T, Inn KS,
Huang IC, Carnero E, Farzan M, Inoue S, Jung JU and García-Sastre
A: Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to
evade recognition by the host viral RNA sensor RIG-I. Cell Host
Microbe. 5:439–449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Varga ZT, Ramos I, Hai R, Schmolke M,
García-Sastre A, Fernandez-Sesma A and Palese P: The influenza
virus protein PB1-F2 inhibits the induction of type I interferon at
the level of the MAVS adaptor protein. PLoS Pathog. 7:e10020672011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stranden AM, Staeheli P and Pavlovic J:
Function of the mouse Mx1 protein is inhibited by overexpression of
the PB2 protein of influenza virus. Virology. 197:642–651. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia C, Vijayan M, Pritzl CJ, Fuchs SY,
McDermott AB and Hahm B: Hemagglutinin of influenza A virus
antagonizes type I interferon (IFN) responses by inducing
degradation of type I IFN receptor 1. J Virol. 90:2403–2417. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Graef KM, Vreede FT, Lau YF, McCall AW,
Carr SM, Subbarao K and Fodor E: The PB2 subunit of the influenza
virus RNA polymerase affects virulence by interacting with the
mitochondrial antiviral signaling protein and inhibiting expression
of beta interferon. J Virol. 84:8433–8445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang F, Sun X, Zhu Y and Qin W:
Downregulation of miR-146a inhibits influenza A virus replication
by enhancing the type I interferon response in vitro and in vivo.
Biomed Pharmacother. 111:740–750. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shi J, Feng P and Gu T: MicroRNA-21-3p
modulates FGF2 to facilitate influenza A virus H5N1 replication by
refraining type I interferon response. Biosci Rep. May 19–2020.doi:
10.1042/BSR20200158. View Article : Google Scholar
|
|
42
|
Xu G, Yang F, Ding CL, Wang J, Zhao P,
Wang W and Ren H: MiR-221 accentuates IFN's anti-HCV effect by
downregulating SOCS1 and SOCS3. Virology 462–463. 343–350. 2014.
View Article : Google Scholar
|
|
43
|
Kawai T and Akira S: Toll-like receptor
and RIG-I-like receptor signaling. Ann N Y Acad Sci. 1143:1–20.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Alexander WS and Hilton DJ: The role of
suppressors of cytokine signaling (SOCS) proteins in regulation of
the immune response. Annu Rev Immunol. 22:503–529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Akhtar LN and Benveniste EN: Viral
exploitation of host SOCS protein functions. J Virol. 85:1912–1921.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zheng J, Yang P, Tang Y, Pan Z and Zhao D:
Respiratory syncytial virus nonstructural proteins upregulate SOCS1
and SOCS3 in the different manner from endogenous IFN signaling. J
Immunol Res. 2015:7385472015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hashimoto K, Ishibashi K, Ishioka K, Zhao
D, Sato M, Ohara S, Abe Y, Kawasaki Y, Sato Y, Yokota S, et al: RSV
replication is attenuated by counteracting expression of the
suppressor of cytokine signaling (SOCS) molecules. Virology.
391:162–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Deng L, Zeng Q, Wang M, Cheng A, Jia R,
Chen S, Zhu D, Liu M, Yang Q, Wu Y, et al: Suppression of NF-κB
activity: A viral immune evasion mechanism. Viruses. 10:4092018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yeh JX, Park E, Schultz KLW and Griffin
DE: NF-κB Activation promotes alphavirus replication in mature
neurons. J Virol. 93:e01071–19. 2019. View Article : Google Scholar
|
|
50
|
Wei F, Jiang Z, Sun H, Pu J, Sun Y, Wang
M, Tong Q, Bi Y, Ma X, Gao GF and Liu J: Induction of PGRN by
influenza virus inhibits the antiviral immune responses through
downregulation of type I interferons signaling. PLoS Pathog.
15:e10080622019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kumagai Y, Takeuchi O, Kato H, Kumar H,
Matsui K, Morii E, Aozasa K, Kawai T and Akira S: Alveolar
macrophages are the primary interferon-alpha producer in pulmonary
infection with RNA viruses. Immunity. 27:240–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Newby CM, Sabin L and Pekosz A: The RNA
binding domain of influenza A virus NS1 protein affects secretion
of tumor necrosis factor alpha, interleukin-6, and interferon in
primary murine tracheal epithelial cells. J Virol. 81:9469–9480.
2007. View Article : Google Scholar : PubMed/NCBI
|
